Frank E. Thomas - 01 Apr 2022 Form 4 Insider Report for Orchard Therapeutics plc

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Apr 2022, 16:15:43 UTC
Prior SEC filing
07 Jan 2022
Next SEC filing
12 May 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Frank Thomas

Key filing fact

Frank E. Thomas filed Form 4 for Orchard Therapeutics plc on 04 Apr 2022.

Key facts

  • This page summarizes Frank E. Thomas's Form 4 filing for Orchard Therapeutics plc.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Apr 2022, 16:15.

Change

  • Previous filing in this sequence was filed on 07 Jan 2022.
  • Current net transaction value: +$7,474.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ORTX transaction

Ordinary Shares

Purchase

Transaction value
$7,474
Shares
+10,000
Change %
+24%
Price
$0.7474
Shares after
52,081
Date
01 Apr 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.722 to $0.758. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

SEC remarks

Title: President & Chief Operating Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .